Active ingredientIcotinib HydrochlorideCat. No. P-I014-001CAS 1204313-51-8Family · Pharmaceutical analytical standards
Icotinib
A first-generation oral tyrosine kinase inhibitor of the EGFR receptor: synthesised in 2002 and approved in China in 2011, it is used for non-small cell lung cancer with EGFR mutations. This family brings together the active ingredient and labelled standards.
Did you know?Chemically it is a close relative of erlotinib in which part of the molecule is closed into a ring, forming a macrocycle similar to a crown ether.
Go to the active ingredient →Active ingredientIcotinib HydrochlorideCat. No. P-I014-001CAS 1204313-51-8
Isotopically labelledIcotinib-d4Cat. No. P-I014-002CAS 1567366-82-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.